Patents by Inventor Nellie Taleux

Nellie Taleux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180184945
    Abstract: A method and device for detecting a worsening of the cardiopulmonary state of a patient treated by a respiratory assistance device comprising means for gathering and processing parameters which are representative of a first parameter that is representative of the patient's respiratory frequency over a first observation window, e.g. daily; a second parameter that is representative of the percentage of cycles that were initiated by the patient during a second observation window, e.g. daily; and a third parameter that is representative of the usage time of the device during a third observation window, e.g. daily.
    Type: Application
    Filed: June 4, 2015
    Publication date: July 5, 2018
    Inventors: Jean-Christian BOREL, Nellie TALEUX-EYSSAUTIER, Nathalie ARNOL, Renaud TAMISIER, Jean Louis PÉPIN
  • Publication number: 20110064773
    Abstract: The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3?,5?,3-triiodothyronine (rT3), a rT3 derived hormone, or a precursor of rT3, such as T4 in association with a molecule susceptible to promote the formation of rT3, in association with a pharmaceutically acceptable vehicle.
    Type: Application
    Filed: May 16, 2008
    Publication date: March 17, 2011
    Applicants: UNIVERSITE JOSEPH FOURIER, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Xavier Leverve, Nellie Taleux, Roland Favier, Michelle Favier, Boris Favier, Yann Favier
  • Publication number: 20110028554
    Abstract: The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3?,3-diiodothyronine (3?,3-T2), 3?,5-diiodothyronine (3?,5-T2), 3?-iodothyronine (3?-T), 3-iodothyronine (3-T) or 5-iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle.
    Type: Application
    Filed: May 16, 2008
    Publication date: February 3, 2011
    Applicants: UNIVERSITE JOSEPH FOURIER, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE SCIENTIFIQUE)
    Inventors: Xavier Leverve, Nellie Taleux, Roland Favier, Michelle Favier, Franck Favier, Boris Favier, Yann Favier